Funding for this research was provided by:
Bristol-Myers Squibb (N/A)
Article History
Received: 3 March 2020
Accepted: 13 December 2020
First Online: 11 January 2021
Ethics approval and consent to participate
: Not applicable
: Not applicable
: TAS: employee and shareholder of Bristol Myers Squibb (at the time of the analysis; a former employee at present); LD: employee and shareholder of Bristol Myers Squibb; KLW: research grants: Bristol Myers Squibb and Pfizer; Consulting fees: AbbVie (>$10,000), Bristol Myers Squibb, Gilead, Lily, Pfizer and UCB.